Further analysis revealed that CPA4 expression was significantly associated with depth of invasion (P = 0.023), lymph node metastasis (P = 0.043), distant metastasis (P = 0.045) and clinical stage (P = 0.022) (Table 1). The gene discussed is CPA4; the disease is metastatic malignant neoplasm in the lymph nodes.